Brind.

Biotech Company Aims to Restore Ecological Functions Using Mammoth Genetic Traits

1 report, 1 independent Updated Sun 00:00
AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Colossal Biosciences is engaged in a project to recreate certain characteristics of the extinct woolly mammoth in an Asian elephant, which is the mammoth's closest living relative. The company is introducing selected genetic traits into the elephant to study cold adaptation, which was necessary for the mammoths to survive in harsh northern hemisphere environments. The company has stated that this work is linked to the broader goal of restoring ecological functions on Earth.

From moneycontrol.com

Why it matters

Some supportBrind's analysis of the reports

The project attracts significant attention due to its ambitious goals in biotechnology. Colossal Biosciences receives ongoing functional and financial support for its research from Menzies Institute for Medical Research. Furthermore, the CIA's investing arm, In-Q-Tel, provides financial backing and investment to the company.

From moneycontrol.com

Who's involved

Keep exploring

The entities involved

Related events

Coverage

Newest first; wire copies grouped